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Five different enzymatic activities, catalyzed by both microsomal
and mitochondrial cytochrome P450 monooxygenases (CYPs), are
strongly implicated in the biosynthesis of ecdysone (E) from cho-
lesterol. However, none of these enzymes have been characterized
completely. The present data show that the wild-type genes of two
members of the Halloween family of embryonic lethals, disem-
bodied (dib) and shadow (sad), code for mitochondrial cyto-
chromes P450 that mediate the last two hydroxylation reactions in
the ecdysteroidogenic pathway in Drosophila, namely the C22- and
C2-hydroxylases. When sad (CYP315A1) is transfected into Dro-
sophila S2 cells, the cells metabolize 2-deoxyecdysone (2dE) to E
and the [3H]ketotriol (2,22-dideoxyecdysone) to 22-deoxyecdys-
one. In contrast, dib (CYP302A1) is responsible for the conversion
of the [3H]ketotriol to [3H]2dE. When cells are transfected with
both dib and sad, they metabolize the [3H]ketotriol to [3H]E in high
yield. The expression of sad and dib is concentrated within the
individual segments of the developing epidermis when there is a
surge of ecdysteroid midway through embryogenesis. This result
occurs before the ring gland has developed and suggests that the
embryonic epidermis is a site of ecdysteroid biosynthesis. This
pattern then diminishes, and, during late embryogenesis, expres-
sion of both genes is concentrated in the prothoracic gland cells of
the developing ring gland. Expression of dib and sad continues to
be localized in this endocrine compartment during larval develop-
ment, being maximal in both the late second and third instar
larvae, about the time of the premolt peaks in the ecdysteroid titer.
S teroid hormones control many aspects of reproduction,development, and homeostasis in higher organisms (1). In
arthropods, steroid hormones play equal or even more vital
developmental roles, especially in mediating transitions between
developmental stages (2, 3). Indeed, the first evidence that
steroid hormones act at the transcriptional level came from
studies of the effects of ecdysone (E) on dipteran polytene
chromosomes more than four decades ago (2, 3). The molting of
larval Drosophila melanogaster, for example, is initiated by the
synthesis and release of the steroid hormone E from the
prothoracic gland cell portion of the ring gland in response to a
neuroendocrine signal (2). E is then converted to the principal
molting hormone, 20-hydroxyecdysone (20E), by a P450 enzyme
in peripheral target tissues. The regulatory effects of 20E are
mediated through activation of a nuclear hormone receptor,
resulting in the transcriptional cascades appropriate for eliciting
specific developmental events (3, 4).
To facilitate the identification and characterization of the
enzymes responsible for ecdysteroid biosynthesis in Drosophila,
we used a combined molecular genetic and biochemical ap-
proach (5) that was based on recent data that identified the
product of the disembodied (dib) locus as being potentially
involved in the biosynthesis of ecdysteroids and as a member of
a new family of cytochrome P450 monooxygenase (CYP)-type
enzymes (i.e., CYP302A1; ref. 6). Mutations in dib result in a
number of striking embryonic phenotypes, including disruptions
in head involution, dorsal closure, gut morphogenesis, and a
failure to produce embryonic cuticle. These developmental
disruptions are accompanied by, or are a result of, low titers of
ecdysteroids, as is the severe reduction in the epidermal expres-
sion of the 20E inducible gene IMP-E1. Several other mutations,
including shadow (sad) and collectively termed the Halloween
group, exhibit similar phenotypes (6, 7). We reasoned that at
least some of these genes might also encode enzymes involved in
E biosynthesis, and perhaps code for CYPs.
Materials and Methods
Insects. The Drosophila mutant strains, dib and sad, were ob-
tained from the Bloomington Stock Center (Bloomington, IN)
and raised on standard cornmealyeast extractdextrose me-
dium (6). Brain-ring gland complexes were dissected from late
second, early third, and late third instar wild-type Drosophila
larvae synchronized at molting, and ovaries were from mature
adults. The latter two tissues were also used for subsequent in
vitro incubation with various radiolabeled intermediates (8, 9).
Prothoracic glands were dissected from late fifth instar Manduca
sexta larvae and frozen (70°C) until thawed and incubated with
various radiolabeled intermediates (10–12).
Ecdysteroid Intermediates. High specific activity 22,23-[3H]-
5[H]-3,14,25-trihydroxycholesta-7-ene-6-one ([3H]ketotriol,
[3H]2,22-dideoxyecdysone, [3H]2,22dE, 60 Cimmol) was a gift
from C. Kappler (Université Louis Pasteur, Strasbourg, France).
2-Deoxyecdysone (2dE) was a gift from R. Lafont (Université P.
et M. Curie, Paris). E and 20E standards were purchased from
SigmaAldrich. The [3H]2dE and [3H]22-deoxyecdysone
([3H]22dE) metabolites were produced by the brief incubation of
extensively homogenized M. sexta prothoracic glands with the
[3H]ketotriol (12). [3H]E (60 Cimmol) was purchased from NEN.
Confirmation of sad as CYP315A1. Adult heterozygous (sadTM3)
genomic Drosophila mutant DNA (two alleles) were amplified by
PCR using the primers 5-AGCGTTTCACAGCCGAGAGC-3
and 5-TGCTGCAGGCATTGTTTTCCTAG-3. Sequencing
used the Thermosequenase cycle sequencing kit (United States
Biochemical) according to the manufacturer’s protocol. In each
Abbreviations: 2dE, 2-deoxyecdysone; 22dE, 22-deoxyecdysone; 2,22dE, 2,22-dideoxyec-
dysone (ketotriol); dib, disembodied; E, ecdysone; 20E, 20-hydroxyecdysone; sad, shadow;
CYP, cytochrome P450 monooxygenase; GFP, green fluorescent protein; ESI, electrospray
ionization.
Data deposition: The sequence reported in this paper has been deposited in the GenBank
database [accession no. AY079170 (sad)].
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resulting sequence, both mutant sad alleles were identified by the
appearance of two bases at a given position in the sequence.
Phenotypes of Wild-Type and Mutant sad and dib Embryos. Cuticle
preparations, spectrin staining, and IMP-E1 expression in em-
bryos have been described previously (6). See Fig. 5 and
accompanying text, which are published as supporting informa-
tion on the PNAS web site, www.pnas.org.
RIA. Wild-type embryos (6–12 h old), or a mixed population of
heterozygous and homozygous mutant sad embryos (6–12 h old)
resulting from the mating of sadTM3-arm-GFP reporter adults
(6) or else selected homozygous sad embryos (10–14 h old)
mechanically sorted for their lack of green fluorescent protein
(GFP) fluorescence (Copas Select, Harvard Bioscience, Hollis-
ton, MA), were homogenized and extracted exhaustively with
methanol. The pooled solvents were evaporated, and the resi-
dues, along with the selected residues of samples after their
RP-HPLC or TLC purification, were subjected to RIA. The H22
antibody was used for embryo titers (13), and the SHO3 antibody
for chromatography residues (14). Results are expressed in
ecdysone equivalents.
Full-Length Coding Sequence for sad. The entire cDNA sequence
for sad was amplified from a Drosophila embryonic cDNA
library in pNB40 (15) by PCR using a novel amplification
protocol (16) that generates two complimentary strands of DNA
containing the cDNA of interest and the plasmid. In this
protocol, two pairs of primers were designed, primers A  B on
the 5 end and C  D on the 3 end of the sad sequence: SadA,
5-GATTCGCACCAGGAGCTGGTC-3; SadB, 5-CTTAGC-
CTGAGCCTCTTCCGTTC-3; SadC, 5-GCGACCAATG-
CAAGACCGCTG-3; and SadD, 5-CGTGTGGCACTCAAG-
CAGCTC-3.
Whole-Mount RNA in Situ Hybridization of sad and dib. Tissue
fixation, RNA hybridization, and detection were done according
to standard protocols (6). Sad sense and antisense riboprobes
were synthesized from the NB40 plasmid containing the 1.8-kb
sad cDNA full-length coding sequence and labeled with digoxi-
genin according to protocols for SP6 and T7 polymerases
(Boehringer Mannheim).
An alternative protocol was used for obtaining the probe used
for the in situ hybridization of second and third instar larval
brain-ring gland complexes. Dib and sad PCR fragments were
synthesized by using the following specific primers and late third
instar larval total RNA: (dibUp1) GCGAAAAGACCAGAG-
TAACG; (dibDo1) CCCACAGCCTTTCAATCACA;
(sadUp1) GTGCGAATCCTTAGCCTGAG; and (sadDo1)
TACGCTGTCAACGGGCATCT. Each cDNA was purified,
cloned into the PGEMT-easy vector (Promega), and labeled as
above.
Transfection of S2 Cells. S2 cells were transfected (17) with either
the wild-type sad or dib (6) gene under the control of the actin
5C promoter or with a control construct constitutively expressing
the GFP protein (18). Sad or dib cDNA was cloned as a
HindIIINot into the StuINot of the S2 expression vector
pBRAcpA (19). The GFP expression construct was generated by
subcloning GFP into pRactAdh.
Incubation of Transfected S2 Cells with Ecdysteroid Precursors. Three
days after the transfection of S2 cells with dib, sad, dib and sad
together, or the GFP (control) expression vector constructs, the
M3 medium from the cell (8  106) culture was replaced with
fresh medium (1 ml) containing DMSO (1%), Tween 80
(0.001%), and the [3H]ketotriol or [3H]22dE (each 105 dpm, 1
nM) or the nonlabeled 2dE substrate (6.5 gml, 14.5 M) and
incubated at 25°C for 2 h or 8 h. Various ecdysteroid standards
(1 g) were added to samples containing radiolabel before their
exhaustive extraction with methanol. The pooled solvents were
evaporated, the residues were taken up in 30% methanol, and
the solutions were kept at 20°C until analyzed by RP-HPLC,
TLC, and MS.
Chromatography. Equipment and procedures for RP-HPLC and
normal phase TLC have been described previously (8–12). For
MS analysis, after sequential RP-HPLC and TLC purification of
Fig. 1. Theoretical scheme of ecdysone biosynthesis (2). Dietary cholesterol or phytosterols serve as the ultimate precursors for the synthesis of 20E, because
insects cannot synthesize sterols from simple carbon molecules. The intermediate resulting from the subsequent oxidation of 7dC has not been identified
unequivocally, but a number of in vivo and in vitro studies suggest that: (i) it is the ketodiol (2,22,25dE) or its 3-dehydro derivative; (ii) these complex reactions
are catalyzed by one or more CYP enzymes present within the mitochondria; and (iii) the delivery of 7dC from the endoplasmic reticulum to these enzymes may
be rate-limiting for the production of E. The sequential hydroxylations of the ketodiol at carbon 25 (to the ketotriol), carbon 22 (to 2dE by dib), carbon 2 (to E
by sad), carbon 20 (activation to 20E), and carbon 26 (inactivation to 20,26E) are catalyzed by CYP enzymes present in the microsomal andor mitochondrial
compartments (2, 5).
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the sad 2dE metabolite, i.e., E, the residue was subjected to
RP-HPLC (isocratic 15% acetonitrile)electrospray MS (ESI-
MS, Thermo Finnigan Quadrupole Electrospray, San Jose, CA).
Enzymatic Treatment of Ecdysteroid Metabolites. After RP-HPLC
andor TLC analysis of tritiated metabolites from transfected S2
cell incubations, purified products were subjected to further
biochemical modification by incubation with M. sexta day seven,
fifth larval instar prothoracic gland homogenates (10), midgut
microsomes (12), or Drosophila third larval instar brain ring
gland complexes (9, 11) or adult ovaries (8). The extracted
residues were analyzed by additional RP-HPLC and TLC.
Results
Confirmation of sad as CYP315A1. Using information from the
Drosophila genome project (http:f lybase.bio.indiana.edu; ref.
20), we searched for a correlation between predicted chromo-
somal locations of CYP enzymes and the known genetic map
positions for several Halloween group mutations. For the sad
gene located at the 86F6–87A7 cytological interval of the third
chromosome (7), we identified CYP315A1 (87A2) as a potential
candidate CYP for the product of this locus. To confirm the
tentative identity of sad, genomic DNA from two different sad
mutant alleles were sequenced, and, in each case, a base alter-
ation was identified that leads to formation of a stop codon. For
sadZ309, glutamine 126 was converted to a stop codon whereas for
sadZ804, tryptophan 442 was converted to a stop codon. Both
mutations are presumed to be null alleles because each would
eliminate the C-terminal positioned heme-binding site that is
required for catalytic activity of all cytochrome-P450 enzymes.
Phenotype of Mutants. See Fig. 5.
Embryonic Ecdysteroid Titers. Ecdysteroid levels were decreased by
50% relative to wild type in the mixed 6- to 12-h embryo
population (i.e., 25% homozygous sad, 50% heterozygous sad
balancer) collected from mated sadTM3-arm-GFP adults, i.e.,
wild type  54.28  14.15 pgmg wet weight (SD) vs. sad 
25.52  9.89 pgmg (P  0.0004). Ecdysteroid titers in machine-
selected homozygous sad embryos (10–14 h old) were below
assay sensitivity using the H22 antibody, i.e., 1.6 pgmg wet
weight.
In Situ Expression of sad and dib. To determine whether the sad
gene product was a candidate for a modulator of E synthesis (Fig.
1) during development, the expression pattern of sad mRNA was
analyzed during embryonic and postembryonic development
and compared with that of dib. A full-length sad cDNA was used
as a probe in Northern analysis, and the data revealed a single
transcript of 1.8 kb at several developmental stages (data not
shown). Using this cDNA as a riboprobe, in situ hybridization to
blastoderm stage embryos demonstrated an early anterior en-
richment of sad transcription (Fig. 2A) although much less than
that found for dib (6). There was no sad mRNA in unfertilized
eggs, suggesting that there is no maternal contribution of sad, as
was noted for dib (6). By the time of complete germ band
extension, sad expression was resolved into stripes, and, by stage
10–11, its expression was very reminiscent of a segment polarity
gene, in that transcription occurred in a portion of the epidermis
of every parasegment. Dib was also expressed in epidermal cells
at this time, although its striped pattern is not as pronounced as
that of sad (6). After stage 11, the expression of sad faded from
all tissues and then resumed in the primordia of the ring gland
at stage 15. This picture continued through the remainder of
embryogenesis in the prothoracic gland cell component of the
ring gland, and later within the larval ring gland. In adult
females, both sad and dib transcripts are expressed strongly in the
follicle cells, another site of ecdysteroid synthesis (2, 3, 5, 6).
Unlike dib, however, sad is also expressed in the nurse cells.
Because the ecdysteroid titer varies during the molting cycle
(3), we determined whether the transcriptional activity of dib and
sad correlates with these changes during larval development by
examining the expression of dib and sad in the ring gland during
the second and third larval instars (Fig. 2B). The data show that
both dib and sad are expressed strongly in late second and third
instar larvae. However, just after ecdysis to the third instar, dib
and sad are down-regulated dramatically.
Characterization of the Roles of sad and dib. Three days after
transfection with sad, S2 cells were incubated with 2dE (see Fig.
1) for 8 h, and the medium and cells were then extracted and
analyzed by RP-HPLCRIA (Fig. 3). The data reveal that S2
cells transfected with sad (CYP315A1) metabolize the 2dE
substrate solely into E. No such activity was observed in GFP
(control)-transfected cells. Over the 8-h incubation period, 0.25
g E was recovered from the 6.5 g 2dE added to the incubation
mixture, a yield of 3.9% at a substrate concentration of 14.5 M.
Additional kinetic analysis revealed a Km of 10.3 M and a Vmax
of 1 nmol8 h for this enzyme (data not shown). The charac-
terization of this product as E was not only qualitatively consis-
Fig. 2. (A) In situ expression pattern of sad. (a) Cellular blastoderm stage
embryo; (b) germ band extension stage 8, segmental staining appears in the
epidermal cells; (c) stage 10–11 embryo showing segment polarity type ex-
pression; (d) ring gland expression in a stage 17 embryo; (e) expression in the
prothoracic gland cells of the ring gland of a third instar larva; ( f) stage 10
ovary. (B) Cycling of dib and sad expression between the second (L2) and third
(L3) instar. In situ hybridization pattern of dib (a–c) and sad (d–f ) within the
prothoracic gland cells of the ring gland. (a and d) Late L2 larval brain-ring
gland complex; (b and e) early L3 larval brain-ring gland complex; (c and f ) late
L3 larval brain-ring gland complex. Rg, Ring gland; br, brain; vg, ventral
ganglion.








tent with its UV spectrum (UVmax 248 nm, data not shown), but
also quantitatively consistent with both specific UV absorption
and ecdysteroid immunoreactivity (Fig. 3). The identity of this
product was confirmed by RP-HPLCESI-MS after additional
normal phase TLCRIA analysis (Fig. 3 Insets). Note the
molecular ion (M  1) at 465 and the sequential loss of four
molecules of water at (M  1)-H2O(1–4), characteristic of
E (21).
Further confirmation of ecdysteroid-specific 2-hydroxylase
activity after sad expression in S2 cells was obtained on incu-
bation of these cells with the [3H]ketotriol substrate, i.e.,
[3H]2,22-dideoxyecdysone ([3H]2,22dE; see Fig. 1). In this case,
[3H]2,22dE (1 nM) was converted to [3H]22-dE (34.7%) and a
conjugate of an unidentified metabolite (28.8%) over the 8-h
incubation period, i.e., 63.5% total substrate metabolism (Fig.
4A; 14.4% after 2 h, data not shown). GFP (control)-transfected
cells did not metabolize the [3H]ketotriol substrate significantly.
This [3H]22dE product comigrated in TLC (Fig. 4A Inset) with
the standard [3H]22dE metabolite produced from the [3H]ke-
totriol by enzymatic activity present in M. sexta prothoracic gland
homogenates in vitro (12). We conclude from the data that sad
(CYP315A1) codes for the ecdysteroid C2-hydroxylase (Fig. 1).
To examine Dib function, we performed a similar RP-HPLC
analysis (Fig. 4B). S2 cells transfected with dib were also able to
metabolize this same [3H]ketotriol substrate, but, in this case, the
sole product was [3H]2dE, i.e., 82.8% in 8 h (47.7% after 2 h, data
not shown). The identity of this product was confirmed by its
comigration in TLC with standard 2dE (Fig. 4B Inset) and its
subsequent facile in vitro metabolism to E by M. sexta prothoracic
glands (data not shown). As a result, we conclude that dib
(CYP302A1) codes for the ecdysteroid C22-hydroxylase (Fig. 1).
As a final confirmation of these conclusions, S2 cells were
cotransfected with both sad and dib and incubated with the
[3H]ketotriol. In this case, the [3H]ketotriol substrate was me-
tabolized efficiently to [3H]E in a 51.7% yield after 8 h of
incubation (Fig. 4C). Product identity was confirmed when this
[3H]E comigrated with standard E after TLC (Fig. 4C Inset).
Additional proof of its identity was the demonstration of the
facile conversion of this product to [3H]20E when incubated with
a M. sexta larval midgut microsomal fraction exhibiting 20-
monoxygenase activity (data not shown).
Additional experiments yielded information on the substrate
specificity of Dib. Sad-transfected S2 cells could hydroxylate
both 2dE and the [3H]ketotriol at carbon 2 (i.e., to E and
[3H]22dE, respectively). However, when [3H]22dE was incu-
bated subsequently with dib-transfected cells, no further metab-
olism was observed. This intermediate was also not metabolized
further in vitro by larval brain-ring gland complexes or adult
ovaries (data not shown). Apparently, 22dE is not a substrate for
the 22-hydroxylase coded for by dib, either in transfected S2 cells
or within Drosophila endocrine organs expressing dib and sad.
Discussion
In contrast to the identification of dib by classical molecular
techniques (6), a preliminary identification of sad was achieved
by comparing its known genetic map position (86F6–87A7) to
predicted chromosomal locations of CYP enzymes by using
information from the Drosophila genome project, i.e.,
CYP315A1 at 87A2. This initial correlation was confirmed by
genomic PCR and sequencing when it was found that base
alterations leading to premature stop codons created null alleles
lacking the critical catalytic heme-binding site. The insect genes
most closely related to sad and dib are CYP12A1, a mitochon-
drial P450 from the house fly (22), and CYP12B1 from Dro-
sophila acanthoptera (23). As with these enzymes, Sad contains
a conserved N-terminal amphipathic region required for mito-
Fig. 3. RP-HPLCTLCRIAMS analysis after sad- or GFP-transfected S2 cell incubation (8 h) with the 2dE substrate (30–100% methanol gradient). Ecdysteroid
immunoreactivity was quantified by RIA (11000 of total sample) by using the SHO-3 antibody after incubations with sad (filled circles) or GFP (open circles). UV
absorption was measured at 248 nm (solid line). (Inset, TLC) TLCRIA (chloroformethanol) of RP-HPLC-purified ecdysone (E) product (11000 of total sample).
(Inset, MS) RP-HPLCESI-MS on an LCQDECA (Thermo Finnigan, San Jose, CA) of the TLC-purified E product.
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chondrial import (24). Indeed, colocalization of a mitochondrial
marker with epitope-tagged versions of Dib and Sad was ob-
served after transient transfection in S2 cells (G.M., A.P., and
M.B.O., unpublished data).
The characterization of Sad and Dib as the first CYP enzymes
shown definitively to be directly involved in ecdysone biosyn-
thesis was achieved after their transfection into Drosophila S2
cell cultures derived from embryos. Incubation of these cells with
radiolabeled and nonlabeled ecdysteroid precursors demon-
strated conclusively that Dib and Sad catalyze the terminal
hydroxylations of the ecdysteroid molecule at the C22 and C2
positions, respectively (Fig. 1). This identity was confirmed when
S2 cells transfected with both dib and sad were able to metabolize
the ecdysteroid precursor [3H]2,22dE to [3H]E, in exactly the
same manner as occurs when this substrate is incubated with
Drosophila ring glands in vitro (8, 9, 11) or administered in vivo
(J.T.W., unpublished data).
The mutant embryonic phenotype of sad closely resembles
that of dib (ref. 6 and see Fig. 5), most likely a result of the very
low ecdysteroid titers in these embryos. In situ expression of the
Fig. 4. RP-HPLCTLC analysis of ecdysteroids after sad-, dib-, sad and dib-, or GFP-transfected S2 cell incubations with the [3H]ketotriol (2,22dE) substrate. (A)
sad (filled circles) or GFP (open circles)  [3H]ketotriol. ?, Unidentified metabolite conjugate. (Inset) TLC analysis of [3H[22dE product. (B) dib (filled circles) or GFP
(open circles)  [3H]ketotriol. (Inset) TLC of [3H]2dE product. (C) sad and dib (filled circles) or GFP (open circles)  [3H]ketotriol. (Inset) TLC of [3H]E (ecdysone)
product.








two genes during Drosophila development is also quite similar
(Fig. 2). Understanding both the temporal and tissue-specific
regulation of the synthesis of these P450 enzymes should eluci-
date the control of ecdysone biosynthesis as well as provide new
insights into Drosophila embryonic and postembryonic develop-
ment per se. For example, ecdysteroid levels begin to rise during
early embryogenesis at about the time of gastrulation (stage 6–7,
3 h after egg laying) and peak at stage 11–12 (7–9 h after egg
laying) during germ band shortening (25), i.e., about the time
when sad expression is strongly localized in the region of
epidermal stripes. This result occurs hours before the formation
of the embryonic ring gland at stage 15 (11–13 h after egg laying),
although the first appearance of progenitor prothoracic gland
cells derived from the dorsal wall of the invaginating stomo-
daeum has been noted at 9–10 h (26). The striped pattern of sad
expression is particularly notable in light of recent findings that
retinoid-elicited patterning along the vertebrate anterior-
posterior axis depends on the different spatial distributions of
the P450-type enzymes involved in retinoid biosynthesis and
degradation (27–30). By such source and sink mechanisms,
gradients of hormone may be established in regional specific
ways (31), which in turn could influence tissue development.
These findings suggest strongly that the expression of sad, like
dib, is absolutely required for the embryonic production of E. In
fact, the data support the hypothesis that ecdysteroids are
synthesized de novo during Drosophila embryogenesis, perhaps
within the epidermal segments. That is, a sterol or ecdysterol
precursor which at the least lacks the 22- and 2-hydroxyl
functions of E (see Fig. 1), is converted to ecdysteroid by the
sequential action of Dib and Sad. The role of maternal RIA-
positive ecdysteroid conjugates (32–34) and their possible con-
tribution to this mid-embryonic surge awaits future research.
Nevertheless, during larval development, the level of sad and dib
transcripts within the prothoracic gland cells of the ring gland
appear to cycle in concert with increases in the premolt hemo-
lymph ecdysteroid titer (35, 36) at the end of both the second and
third instars (Fig. 2B). In addition, both dib and sad are
completely down-regulated between the instars. These initial
observations provide the base necessary for critical analysis of
the control of hormone levels in a genetic system.
The present data indicate that two key mitochondrial CYP
enzymes that participate in E biosynthesis have been identified
and suggest that our approach will facilitate the characterization
of the remaining unidentified P450 enzymes implicated in the
ecdysteroidogenic pathway (Fig. 1). Indeed, we have found
recently that the Halloween genes phantom, shade, and spook
also exhibit defects in ecdysteroid biosynthesis and all code for
CYP300 level enzymes, but of the microsomal class (A.P.,
J.T.W., L.I.G., and M.B.O., unpublished data). As such, they
likely function before the action of dib and sad. The complete
characterization of their gene products and those of other P450
genes in the pathway leading to 20E should set the stage for
understanding the biochemical and molecular control of steroid
molting hormone production in this dipteran model. Finally,
because all insects require ecdysteroids for proper development,
these specific CYP enzymes may provide novel targets for the
development of agents that can be used for the control of insects
of both agricultural and biomedical importance.
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